Adult PFIC: Why Some People Spend Years Searching for Answers
- A hidden diagnosis: Although PFIC is widely considered a childhood condition, some people do not experience recognizable symptoms until adulthood, leaving many undiagnosed or misdiagnosed for years
- The cost of missed recognition: While adults search for answers, liver damage may continue silently progressing, alongside the physical and emotional impact of symptoms such as itching, fatigue and uncertainty
- No one should navigate PFIC alone: Through initiatives like PFIC Colors, developed with the PFIC Network, we are helping people better understand PFIC, connect with trusted support and feel empowered to seek answers and specialist care
What is adult PFIC?
PFIC is a group of rare inherited liver conditions that affects the body’s ability to transport and circulate bile, which is essential for digesting and absorbing fats, as well as removing waste products.1–5 When bile builds up in the liver , it can damage the liver and cause symptoms such as itching.1
While PFIC is often associated with childhood, it is increasingly recognized that it can also manifest in adults.3,6 In these cases, symptoms may not appear until later in life, sometimes triggered by events such as pregnancy or an infection.2,6
For many, this means years of unexplained symptoms, repeated medical appointments and uncertainty before the underlying cause is identified.6
What is the impact of PFIC?
For adults living with PFIC, the condition can affect nearly every aspect of life, from physical health and emotional wellbeing to work, relationships and future plans.6
Common symptoms include itching (pruritus), yellowing of the skin and eyes (jaundice), abdominal pain, diarrhea and fatigue, which can disrupt everyday activities and quality of life.7,8
For many, the most challenging symptom is the relentless, debilitating itching. Because itching has no visible signs, its severity is often underestimated, making it difficult for others to understand the exhausting and all-consuming burden, which can extend far beyond physical symptoms.1,6,9,10
Severe itching can affect concentration, work, education, family life, relationships and mental wellbeing. Sleep disruption caused by persistent itching can leave people exhausted during the day, while the unpredictability of symptoms and their underlying cause may also create anxiety about the future.1,10–13
Many people describe feeling isolated, particularly because PFIC is rare and poorly understood by others.6
Moreover, PFIC is a progressive condition, which means it can evolve over time. One of the challenges of the disease is that underlying changes in the liver may continue even when symptoms fluctuate or seem manageable. As a result, individuals may feel relatively well while the disease remains active beneath the surface.6
Without appropriate care, bile continues to build up in the liver, which can cause long-term damage and may eventually lead to liver failure.1,6,14
Why is a diagnosis of adult PFIC so challenging?
Adult PFIC is often misdiagnosed or diagnosed much later than it should be. This is primarily driven by limited awareness and understanding in adults.6,13 The long-held perception of PFIC as a childhood condition can mean healthcare professionals (HCPs) may not immediately suspect it in adults.6,14
Contributing to this challenge is that the condition rarely presents in a straightforward or predictable way. Some adults may have mild or no obvious symptoms at all.6,15 For those who do experience symptoms, they often overlap with those of other, more common conditions.6 In some cases, symptoms come and go over time,6 making it difficult to identify the underlying cause.
As a result, PFIC is often overlooked, dismissed or attributed to other causes,6,13 which can leave people feeling frustrated and unsupported. Indeed, many adults with PFIC spend years, or even decades, searching for answers, often only managing symptoms without optimal care – all the while, liver damage may continue to progress.6
How can we bridge the diagnostic gap in PFIC?
Earlier recognition is essential to changing the disease trajectory and improving long-term outcomes for adults with PFIC.16,17 The first step is increasing awareness of adult PFIC, so that symptoms are recognized in this context sooner and appropriate testing can take place.6
When PFIC is suspected, genetic testing is often used to confirm the diagnosis.16,17 Because the condition is caused by changes in certain genes, genetic testing can identify the underlying cause. However, genetic variants are not always found.18,19 In some cases, a diagnosis is ultimately made through a comprehensive clinical assessment and the exclusion of all other possible causes.18,19
A confirmed diagnosis can be an important turning point
For some people, finally receiving a diagnosis provides a long-awaited validation that their symptoms have a genuine underlying cause. It can also open the door to specialized care and access to a supportive community.17
When should PFIC be considered?
Could PFIC be the missing explanation? Adults with the following symptoms or experiences may benefit from discussion with a liver specialist:3,6,17,19
- Persistent or recurrent unexplained itching
- Cholestasis or unexplained abnormalities in liver tests
- Episodes of jaundice
- Family history of liver disease
- Symptoms that have remained unexplained despite previous investigations
- Ongoing liver problems with no clear cause
- History of severe or recurrent intrahepatic cholestasis of pregnancy (ICP)
How Ipsen supports the PFIC community
At Ipsen, we recognize that for many adults living with PFIC, obtaining a diagnosis can be a life-changing moment. Beyond advancing science, we are committed to listening to the experiences of people living with rare cholestatic liver diseases and helping raise awareness of the challenges they face.
Through collaboration with patient organizations and the wider rare disease community, we aim to support earlier recognition, improve understanding and help individuals access the care they need.
To help make sense of PFIC’s complexity, we joined with the PFIC Network to co-create the PFIC Colors campaign. This initiative organizes information into six color-coded topic areas, providing a clear navigation framework to help families understand the full spectrum of the PFIC journey.
This year, through our PFIC Colors platform, Ipsen is supporting the PFIC Community Awareness Day campaign, ‘See the Whole Picture’, with a focus on the often overlooked adult PFIC population. We are also encouraging engagement with PFIC Community stories, which will be shared across social media.
By reflecting these diverse lived experiences, we help ensure families receive meaningful support throughout their experience – from diagnosis onward.
Explore the resources here
- Learn about the color-coded framework: Visit our campaign hub PFIC Colors: Making Sense of PFIC with the PFIC Network
- Access community support: Visit PFIC.org for trusted, community-developed resources and connection for people living with PFIC
Q&A
Some adults with PFIC may experience mild symptoms or symptoms that come and go, which can make the condition difficult to recognize.6 A history of unexplained bile flow problems, jaundice or severe, ongoing itching may be associated with PFIC and could prompt further medical evaluation.
If you are concerned about your health or think you may have PFIC, please speak with your doctor or another qualified healthcare professional.
Because PFIC symptoms can be similar to those of other liver conditions, symptoms alone are often not enough to confirm a diagnosis.6 Genetic testing looks for the gene changes known to cause PFIC. Identifying a specific genetic variant helps healthcare teams tailor the most appropriate care plan, as some management options may be guided by specific genetic results. However, even if a test does not find a known variant, a PFIC diagnosis can still be made by ruling out all other possible causes.17,19
Because our understanding of PFIC is advancing so rapidly, new genes are constantly being discovered and new testing methods are being developed. If a genetic test does not find a known genetic variant, this does not necessarily rule out PFIC or another genetic cause. As knowledge and testing methods develop, genetic test results may sometimes be re-evaluated or testing may be repeated. The meaning of an inconclusive result will depend on the individual’s circumstances and should be discussed with a healthcare professional.20
If you have questions about a genetic test result, please speak with your doctor or another qualified healthcare professional.
You are not alone. If you have concerns about possible symptoms or questions about PFIC, your doctor or healthcare team should be your first point of contact. They can help guide you to appropriate information and support resources.
For additional trusted information and the opportunity to connect with others affected by PFIC, visit PFIC Network. The organization provides resources, education, and support for people living with PFIC and their families. You can also find a local PFIC organization in your region through their Global Support Directory.
Please note: This information is intended for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Please speak with your doctor or healthcare team if you have questions or concerns about your health or the possibility of PFIC.
References
1. Kamath BM, et al. 2020. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis. Liver Int. 40(8):1812–1822.
2. Henkel SA, et al. 2019. Expanding etiology of progressive familial intrahepatic cholestasis. World J Hepatol. 11(5):450–463.
3. Davit-Spraul A, et al. 2009. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis. 4:1.
4. Goldberg A, Mack CL. 2020. Inherited Cholestatic Diseases in the Era of Personalized Medicine. Clin Liver Dis 15(3):105–109.
5. van Wessel DBE, et al. 2020. Genotype correlates with the natural history of severe bile salt export pump deficiency. J Hepatol. 73(1):84–93.
6. Berg T. 2024. Progressive Familial Intrahepatic Cholestasis in Adulthood: Genetics, Diagnosis, Treatment, and Further Research. EMJ Hepatol. 12[Suppl 2]:2–7.
7. Mehl A, et al. 2016. Liver transplantation and the management of
progressive familial intrahepatic cholestasis in children. World J
Transplant. 6(2):278-290.
8. Halawi A, et al. 2021. Triggers of benign recurrent intrahepatic cholestasis and its pathophysiology: a review of literature. Acta Gastroenterol Belg. 84(3):477–486.
9. Patel SP, et al. 2019. Cholestatic pruritus: Emerging mechanisms and therapeutics. J Am Acad Dermatol. 81(6):1371–1378.
10. Brown K. 2025. Update on the Management of Cholestatic Pruritus. Gastroenterol Hepatol (NY). 21(5):315–317.
11. Langedijk JAGM, et al. 2021. Cholestasis-Associated Pruritus and Its Pruritogens. Front Med (Lausanne). 8:639674.
12. Tajiri K, Shimizu Y. 2017. Recent advances in the management of pruritus in chronic liver diseases. World J Gastroenterol. 23(19):3418–3426.
13. Canadian Agency for Drugs and Technologies in Health. 2024. Odevixibat (Bylvay): CADTH Reimbursement Recommendation: Indication: The treatment of pruritus in patients aged 6 months or older with progressive familial intrahepatic cholestasis [Internet]. Report No.: SR0788. PMID: 38648297.
14. Baker A, et al. Systematic review of progressive familial intrahepatic cholestasis. 2019. Clin Res Hepatol Gastroenterol. 43(1):20–36.
15. Alam S, Lal BB. 2022. Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies. World J Hepatol. 14(1):98–118.
16. McKiernan P, et al. 2023. Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis. JHEP Rep. 6(1):100949.
17. Gunaydin M, et al. 2018. Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment. Hepat Med. 10:95–104.
18. Vinayagamoorth V, et al. Newer variants of progressive familial intrahepatic cholestasis. 2021. World J Hepatol. 13(12):2024–2038.
19. Bakır A, et al. The molecular landscape of progressive familial intrahepatic cholestasis in Turkey: Defining the molecular profiles and expanding the variant spectrum. Ann Hum Genet 2022; 86:119–126.
20. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on liver transplantation. J Hepatol. 2024;81(6):1040-1086.